newsfilter
← Latest News
Business Wire·

MyMD Announces $15 Million Offering with Existing Investors

MyMD Pharmaceuticals, Inc.® (NASDAQ:MYMD) ("MyMD" or "the Company"), a clinical stage biopharmaceutical company developing groundbreaking therapies for the treatment of serious and debilitating autoimmune and